Is a p53-Regulated Inhibitor of G2/M ProgressionHeiko Hermeking, Bert Vogelstein, Christoph Lengauer et al.|Molecular Cell|1997Cited by 1.2k
Glucose Deprivation Contributes to the Development of <i>KRAS</i> Pathway Mutations in Tumor CellsJihye Yun, Nickolas Papadopoulos, Carlo Rago et al.|Science|2009Cited by 908
Somatic mutations of the mitochondrial genome in human colorectal tumoursKornélia Polyák, Bert Vogelstein, Yunbo Li et al.|Nature Genetics|1998Cited by 839
Contribution of bone marrow–derived endothelial cells to human tumor vasculatureBrock A. Peters, Christoph Lengauer, Luis A. Díaz et al.|Nature Medicine|2005Cited by 480
Precision Targeted Therapy with BLU-667 for <i>RET</i>-Driven CancersVivek Subbiah, Erica Evans, Kevin Wilson et al.|Cancer Discovery|2018Cited by 392